SANJAY JAIN, M.D.
Medical Practice at Wolfe St, Baltimore, MD

License number
Maryland D62787
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 614-3917

Personal information

See more information about SANJAY JAIN at radaris.com
Name
Address
Phone
Sanjay Jain, age 52
326 Southampton Dr APT A, Silver Spring, MD 20903
(301) 408-1555
Sanjay Jain, age 48
5804 N Charles St, Baltimore, MD 21210
Sanjay Jain
12518 Winexburg Manor Dr APT 1, Silver Spring, MD 20906
Sanjay Jain
110 W 39Th St, Baltimore, MD 21210
(410) 235-3235
Sanjay Jain, age 53
10425 Overgate Pl, Potomac, MD 20854
(301) 340-7062

Organization information

See more information about SANJAY JAIN at bizstanding.com

Sanjay Jain MD,MBBS,BS

600 N Wolfe St, Baltimore, MD 21287

Industry:
Radiology, Pediatrician
Phone:
(410) 614-0732 (Phone)
Sanjay Kumar Jain

Professional information

See more information about SANJAY JAIN at trustoria.com
Sanjay Jain Photo 1
Sanjay Jain, Baltimore MD

Sanjay Jain, Baltimore MD

Specialties:
Pediatric Infectious Disease Specialist
Address:
600 N Wolfe St, Baltimore, MD 21287
200 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Bachelor of Medicine, Bachelor of Surgery
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)


Sanjay Jain Photo 2
Sanjay Jain, Baltimore MD

Sanjay Jain, Baltimore MD

Specialties:
Pediatric Infectious Disease Medicine
Age:
48
Address:
600 N Wolfe St, Baltimore 21287
(410) 502-8241 (Phone), (410) 614-8173 (Fax)
1550 Orleans St, Baltimore 21287
(410) 502-8241 (Phone)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone), (410) 955-1464 (Fax)
DIV OF GERIATRIC PSYCHIATRY/JOHNS HOPKINS HOSP
600 N Wolfe St SUITE 1159, Baltimore 21287
(410) 955-6158 (Phone), (410) 955-6158 (Fax)
200 N Wolfe St SUITE 2064, Baltimore 21287
(410) 502-3917 (Phone), (410) 614-1491 (Fax)
Certifications:
Pediatric Infectious Disease Medicine, 2013, Pediatrics, 2010
Awards:
Healthgrades Honor Roll
Languages:
English, Hindi
Education:
Medical School
All India Institute Of Med Sciences New Delhi Delhi India
Graduated: 1999


Sanjay Jain Photo 3
Biosafety Level (Bsl)-3 Life Support Cell For Studying Live Animals

Biosafety Level (Bsl)-3 Life Support Cell For Studying Live Animals

US Patent:
2010031, Dec 16, 2010
Filed:
Jun 16, 2010
Appl. No.:
12/816941
Inventors:
Sanjay K. Jain - Baltimore MD, US
Stephanie L. Davis - Baltimore MD, US
Peter Um - Houston TX, US
Nick Be - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A01K 1/03
US Classification:
119419
Abstract:
A biological safety system includes a life-support cell, a supply system fluidly connected to the life-support cell, and an exhaust system fluidly connected to the life-support cell. The life-support cell is structured to contain a laboratory animal infected with microorganism of a type that requires bio-safety level 3 (BSL-3) isolation, is transparent to at least one form of radiation to permit observation of the laboratory animal while in use, and the biological safety system contains the microorganism that infect the laboratory animal within the life-support cell while permitting the observations of the laboratory animal from a bio-safety level 2 (BSL-2) environment without the microorganism escaping from the life-support cell.


Sanjay Jain Photo 4
Mycobacterium Tuberculosis Persistance Genes

Mycobacterium Tuberculosis Persistance Genes

US Patent:
2008024, Oct 2, 2008
Filed:
Jan 18, 2008
Appl. No.:
12/016465
Inventors:
Sanjay K. Jain - Baltimore MD, US
Gyanu Lamichhane - Baltimore MD, US
William R. Bishai - Baltimore MD, US
International Classification:
A61K 39/00, C12N 1/20, G01N 33/00, A61P 37/00
US Classification:
4241901, 4352523, 435245, 4242481, 436 86
Abstract:
Compositions and methods for preventing infections, particularly persistent, latent Mycobactial infections, are provided. The compositions and methods utilize newly identified genes (and/or corresponding gene products) that are necessary for survival of within a host.